Pankaj Kumar | Immunology and Microbiology | Best Researcher Award

Pankaj Kumar | Immunology and Microbiology | Best 

Pankaj Kumar,The Ohio State University,United States

Pankaj Kumar is a Ph.D. researcher at Ohio State University. His research focuses on cancer biology, immunotherapy, and molecular mechanisms. He has published several papers and received awards for his work.

Publication Profile

orcid

Education

Pankaj Kumar completed his Ph.D. in Molecular and Cancer Biology from CSIR-Centre for Cellular and Molecular Biology (CSIR-CCMB) Hyderabad, India (2014-2021). He received his M.S. in Biotechnology from Babasaheb Bhimrao Ambedkar University (BBAU), Lucknow, India (2011-2013) and B.S. in Biotechnology from Chhatrapati Shahu Ji Maharaj University (CSJMU), Kanpur, India (2008-2011).

Experience

Pankaj Kumar worked as a Postdoctoral Research Scholar at Ohio State University (February 2021-present). He was a Research Fellow (Ph.D.) at CSIR-Centre for Cellular and Molecular Biology, Hyderabad (August 2014-October 2021).

Awards And Honors

Pankaj Kumar received the Keystone Symposia travel award (2019), Carl Storm International Diversity (CSID) fellowship (2018), International Travel grant from ICMR-India (2018), CSIR-NET (Junior/Senior Research Fellowship-2015), and DBT-JRF (Junior Research Fellowship-2014).

Research Focus

Pankaj Kumar’s research focuses on cancer biology, immunotherapy, molecular mechanisms, and drug resistance. His work explores the molecular basis of cancer, multidrug resistance, tumor metastasis, and cancer immunotherapy.

Publications

  1. Hsp90 facilitates acquired drug resistance of tumor cells through cholesterol modulation however independent of tumor progression 📄
  2. The matrix metalloproteinase 7 (MMP7) links Hsp90 chaperone with acquired drug resistance and tumor metastasis 📄
  3. Altered molecular pathways decides the treatment outcome of Hsp90 inhibitors against breast cancer cells 📄
  4. Targeting squalene epoxidase interrupts homologous recombination via the ER stress response and promotes radiotherapy efficacy 📄
  5. Heat shock transcription factor HSF2 modulates the autophagy response through the BTG2-SOD2 axis 📄
  6. Effect Of OSU-ERβ-12, A Carborane-based ERβ-selective Agonist, On Hepatic Fibrosis And NASH 📄
  7. The Battle of LPS Clearance in Host Defense vs. Inflammatory Signaling 📄

Hadi Maleki-Kakelar | Immunology | Best Researcher Award

Assist. Prof. Dr. Hadi Maleki-Kakelar | Immunology | Best Researcher Award

Assist. Prof. Dr. Hadi Maleki-Kakelar, Urmia University of Medical Sciences, Iran

Assist. Prof. Dr. Hadi Maleki-Kakelar is an Assistant Professor at the Solid Tumor Research Center, Cellular and Molecular Medicine Institute, Urmia University of Medical Sciences, Iran. He holds an M.Sc. in Microbiology from the University of Zanjan (2007) and a Ph.D. in Medical Biotechnology from Tabriz University of Medical Sciences (2014).

Education:

Assistant Professor
Solid Tumor Research Center, Urmia University of Medical Sciences, Urmia, Iran
August 2022

Postdoctoral Researcher

Research Center for Pharmaceutical Nanotechnology, Tabriz University of Medical Sciences, Tabriz, Iran
April 2019 – February

Supervisor: Prof. Y. Omidi

Ph.D. in Medical Biotechnology (Sep 2014 – Apr 2019)

Institution: Research Center for Pharmaceutical Nanotechnology, Tabriz University of Medical Sciences (TBZMED), Tabriz, Iran

Thesis: Nano-engineered edible probiotic bacteria to combat Helicobacter pylori

Supervisor: Prof. Y. Omidi

GPA: 20/20

M.Sc. in Microbiology (Sep 2007 – Sep 2010)

Institution: Faculty of Microbiology, Islamic Azad University, Zanjan, Iran

Thesis: Survey of Extracted Secondary Metabolites of Streptomyces spp. with Antibacterial Properties Isolated from Soils of West Azarbayjan and Kordestan Regions

Supervisor: Prof. Y. Omidi

GPA: 19.50/20

Professional Profiles:

ORCID ID

Scopus Profile

Professional Experience:

Classification and Genotyping of Bacteria: Conducting research on bacterial species identification using advanced genotyping techniques, contributing to the understanding of bacterial diversity and its applications in medicine.

DNA Extraction: Performing high-quality DNA extractions from various biological samples, ensuring the integrity and purity of DNA for downstream molecular applications.

Isolation and Molecular Identification of Marine Microorganisms: Isolating unique marine microorganisms with potential pharmaceutical properties and using molecular methods such as 16S rRNA sequencing for species identification.

Cloning and Expression of Recombinant Proteins: Cloning genes of interest and expressing recombinant proteins in bacterial or mammalian systems to study their potential applications in drug development and biotechnology.

PCR, qRT-PCR: Employing PCR and quantitative PCR (qRT-PCR) techniques to analyze gene expression and detect specific genetic markers in bacterial and mammalian samples.

Cell Culture and Bacterial Culture: Managing cell culture techniques, including maintaining mammalian and bacterial cell lines, to support research in drug discovery and pharmaceutical nanotechnology.

Synthesis of Nanoparticles: Synthesizing nanoparticles, including gold nanoparticles, for use in drug delivery systems, cancer therapy, and diagnostic applications.

Working with Animal Models: Designing and conducting experiments using animal models (mice, rats, and rabbits) to study the in vivo effects of pharmaceutical compounds and nanomaterials in therapeutic research.

Research Interests:

His research focuses on cellular and molecular biotechnology, including nano-engineered probiotic bacteria for combating Helicobacter pylori. Dr. Maleki-Kakelar is a dedicated researcher with a strong background in microbiology, nanotechnology, and biomedical sciences.

Top Notable Publications:

Recent advances in the application of engineered exosomes from mesenchymal stem cells for regenerative medicine

European Journal of Pharmacology

2025-02

DOI: 10.1016/j.ejphar.2024.177236

Contributors: Reza Abbasi, Ghazal Alamdari-Mahd, Hadi Maleki-Kakelar, Razieh Momen-Mesgin, Mahdi Ahmadi, Mohaddeseh Sharafkhani, Jafar Rezaie

The role of gut microbiota and probiotics in preventing, treating, and boosting the immune system in colorectal cancer

Life Sciences

2024

DOI: 10.1016/j.lfs.2024.122529

Contributors: Masheghati, F.; Asgharzadeh, M.R.; Jafari, A.; Masoudi, N.; Maleki-Kakelar, H.

Infertility: Focus on the therapeutic potential of extracellular vesicles

Reproductive Biology

2024-09

DOI: 10.1016/j.repbio.2024.100925

Contributors: Ali Parvin, Gisou Erabi, Donna Mohammadpour, Hadi Maleki-Kakelar, Sonia Sadeghpour, Mohammad Reza Pashaei, Mortaza Taheri-Anganeh, Hojat Ghasemnejad-Berenji

Association of endothelial nitric oxide synthase gene polymorphisms with susceptibility to prostate cancer: A comprehensive systematic review and meta-analysis

Urology Journal

2020

DOI: 10.22037/uj.v0i0.5445

Contributors: Abedinzadeh, M.; Dastgheib, S.A.; Maleki, H.; Heiranizadeh, N.; Zare, M.; Jafari-Nedooshan, J.; Kargar, S.; Neamatzadeh, H.

Towards a new avenue for producing therapeutic proteins: Microalgae as a tempting green biofactory

Biotechnology Advances

2019-12

DOI: 10.1016/j.biotechadv.2019.107499

Contributors: Dehghani J; Adibkia K; Movafeghi A; Maleki-Kakelar H; Saeedi N; Omidi Y

Lactobacillus plantarum induces apoptosis in gastric cancer cells via modulation of signaling pathways in Helicobacter pylori

BioImpacts

2019-06

DOI: 10.34172/bi.2020.09

Contributors: Maleki-Kakelar H; Dehghani J; Barzegari A; Barar J; Shirmohamadi M; Sadeghi J; Omidi Y

Novel dental nanocomposites: Fabrication and investigation of their physicochemical, mechanical, and biological properties

Bulletin of Materials Science

2018

DOI: 10.1007/s12034-018-1589-z

Contributors: Jaymand, M.; Lotfi, M.; Barar, J.; Eskandani, M.; Maleki, H.

Propyl gallate (PG) and tert-butylhydroquinone (TBHQ) may alter the potential anti-cancer behavior of probiotics

Food Bioscience

2018

DOI: 10.1016/j.fbio.2018.05.005

Contributors: Salmanzadeh, R.; Eskandani, M.; Mokhtarzadeh, A.; Vandghanooni, S.; Ilghami, R.; Maleki, H.; Saeeidi, N.; Omidi, Y

Isolation and molecular identification of Lactobacillus with probiotic potential from abomasums driven rennet

Food Chemistry

2018-08

DOI: 10.1016/j.foodchem.2018.08.081

Contributors: Maleki Kakelar H; Barzegari A; Hanifian S; Barar J; Omidi Y

Pathogenicity of Helicobacter pylori in cancer development and impacts of vaccination

Gastric Cancer

2018-08

DOI: 10.1007/s10120-018-0867-1

Contributors: Maleki Kakelar H; Barzegari A; Dehghani J; Hanifian S; Saeedi N; Barar J; Omidi Y

Conclusion:

In conclusion, Dr. Hadi Maleki-Kakelar’s diverse body of work, encompassing significant research in regenerative medicine, cancer immunology, and microbiology, positions him as an exceptional candidate for the Best Researcher Award. His continued pursuit of innovation, dedication to advancing scientific understanding, and ability to generate impactful, globally relevant research make him a leader in his field. Dr. Maleki-Kakelar is undoubtedly deserving of this prestigious recognition, and his work continues to inspire future generations of scientists and researchers.